您的位置: 首页 > 农业专利 > 详情页

METHOD OF PROVIDING CELLULAR THERAPY USING MODIFIED NATURAL KILLER CELLS OR T LYMPHOCYTES
专利权人:
BLOODCENTER RESEARCH FOUNDATION
发明人:
Subramaniam M. Malarkannan
申请号:
US14433082
公开号:
US20150258143A1
申请日:
2013.09.30
申请国别(地区):
US
年份:
2015
代理人:
摘要:
A method of decreasing cytokine production and release is disclosed. In one embodiment, the method comprises the step of providing cytotoxic cells to a subject wherein the cells are preferably natural killer cells or T lymphocytes and are genetically modified to express a chimeric antigen receptor comprising a first element that is an extracellular antigen receptor and a second intracellular element that is a signaling moiety comprising altered ADAP-dependent or Fyn-dependent signaling such that downstream signaling causing cytokine release is decreased. Specific modifications of CD137 and NKG2D cytoplasmic tails are described. Additionally, methods to develop and screen drug compounds capable of compromising the binding between ADAP and Fyn and disrupting the downstream release of cytokines are described.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充